Molecular monitoring of patients with CML is essential to follow the disease evolution and response to treatment. However, the molecular monitoring requires a validated, standardized and robust technology. For these reasons the CML-MPN Quebec Research Group organized a symposium in June 2012 on the molecular monitoring of CML. Below you will find some of the presentations of this symposium. Please note that those presentation are in french.
By Eric Winstall Ph.D. in collaboration with Bruno Lamontagne Ph.D
By Nathalie Girard, PhD and Lambert Busque, MD, FRCPC
By David Faucher PhD and Lambert Busque, MD, FRCPC